Today in News History

On July 12, several notable moments in the history of News stand out. In 1917, The Bisbee Deportation occurs as vigilantes kidnap and deport nearly 1,300 striking miners and others from Bisbee, Arizona. In 1924, Faidon Matthaiou, Greek basketball player and coach (died 2011) was born. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1947, Richard C. McCarty, American psychologist and academic was born. In 1971, Andriy Kovalenco, Ukrainian-Spanish rugby player was born. In 1974, Stelios Giannakopoulos, Greek footballer and manager was born. In 1982, Jason Wright, American football player, businessman, and executive was born. In 1997, Malala Yousafzai, Pakistani-English activist, Nobel Prize laureate was born. In 2000, Vinícius Júnior, Brazilian footballer was born. In 2012, Alimuddin, Pakistani cricketer (born 1930) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

SA pharma firm Xylomed develops potential Ebola drug

SundayTimes

SundayTimes

·

July 9, 2026

·

lean right
SA pharma firm Xylomed develops potential Ebola drug

A South African pharmaceutical company has developed a candidate treatment for the Ebola virus and is preparing to begin a clinical trial in parts of Africa affected by recurring outbreaks.

Narrative Intelligence Brief

This article was published by SundayTimes, a source frequently categorized with a lean right bias based in South Africa. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of SundayTimes, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 33%

Center 17%

Right 50%


Seeking Alpha

lean right

· Jun 30, 2026

Ligand Pharmaceuticals: The Bull Case Is A Biotech ARM, The Bear Case Is Just Another Royalty Trust

Ligand Pharmaceuticals: The Bull Case Is A Biotech ARM, The Bear Case Is Just Another Royalty Trust

The korea Herald News

center

· Jul 7, 2026

Matica Bio, VaxDome partner on antiviral hybrid vaccine development

Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered with Texas-based VaxDome Inc. to jointly develop an antigen-agnostic antiviral vaccine aimed at protecting against a broad range of infectious diseases. The collaboration will focus on advancing VaxDome's hybrid antiviral vaccine candidates into clinical trials. Under the agreement, Matica Biotechnology will provide process development, analytical development and the producti

China Global Television Network

lean left

· Jul 3, 2026

Why patients are traveling to China for care

Why patients are traveling to China for care

South China Morning Post

lean left

· Jun 22, 2026

China closing in but US leads in biotech quality and commercial reach, survey finds

China, which now conducts more clinical drug trials than the US, still lags in the quality and commercial reach of its biomedical science, according to a recent survey of senior US leaders in industry and academia. The ‌poll, conducted by Cure Innovation Index, found that China is seen as the clear leader in two out of six sectors: clinical development and supply chain. It found that the US leads in moving experimental products through to large-scale production, capital, and commercialisation...

Proto Thema - English

lean right

· Jun 24, 2026

France records first Ebola case as doctor returns from Congo

Health authorities are on high alert after the doctor tested positive for the virus. The patient has been placed in isolation, and contact tracing is under way The post France records first Ebola case as doctor returns from Congo appeared first on ProtoThema English.

UrduPoint

lean right

· Jun 27, 2026

Multinational healthcare companies expand R&D and supply chain links in China

Multinational healthcare companies expand R&D and supply chain links in China

Topics:

World · 5
Business · 1

Related coverage for "SA pharma firm Xylomed develops potential Ebola drug": Seeking Alpha — Ligand Pharmaceuticals: The Bull Case Is A Biotech ARM, The Bear Case Is Just Another Royalty Trust. The korea Herald News — Matica Bio, VaxDome partner on antiviral hybrid vaccine development. China Global Television Network — Why patients are traveling to China for care. South China Morning Post — China closing in but US leads in biotech quality and commercial reach, survey finds. Proto Thema - English — France records first Ebola case as doctor returns from Congo. UrduPoint — Multinational healthcare companies expand R&D and supply chain links in China